L. L. Coelho, Matheus Menezes Vianna, C. F. Lima, M. A. Moreira, A. Bonomo, C. Coutinho, F. Vargas, L. Garzoni
{"title":"Establishment of 3D culture of mammary tumor cells for in vitro therapeutic response studies targeting personalized anticancer therapy","authors":"L. L. Coelho, Matheus Menezes Vianna, C. F. Lima, M. A. Moreira, A. Bonomo, C. Coutinho, F. Vargas, L. Garzoni","doi":"10.35259/isi.sact.2019_32813","DOIUrl":null,"url":null,"abstract":"Introduction: Breast cancer is the second most common type of cancer in the world. Personalized therapy is an option in the fight for the cure of cancer, since tumor variability is a great challenge in the elaboration of therapeutic protocols. Only 5% of the compounds tested in vitro in 2D systems present in vivo antitumor activity. Otherwise, the three-dimensional (3D) cell culture systems, which better mimic the architecture and tumor behavior observed in vivo, respond to in vitro treatment in a similar way to tumors in patients when treated with the same chemotherapeutic agents, showing great potential for evaluation of specific tumor therapy.","PeriodicalId":427855,"journal":{"name":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","volume":"208 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35259/isi.sact.2019_32813","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Breast cancer is the second most common type of cancer in the world. Personalized therapy is an option in the fight for the cure of cancer, since tumor variability is a great challenge in the elaboration of therapeutic protocols. Only 5% of the compounds tested in vitro in 2D systems present in vivo antitumor activity. Otherwise, the three-dimensional (3D) cell culture systems, which better mimic the architecture and tumor behavior observed in vivo, respond to in vitro treatment in a similar way to tumors in patients when treated with the same chemotherapeutic agents, showing great potential for evaluation of specific tumor therapy.